Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ensartinib (X-396) a novel drug for anaplastic lymphoma kinase-positive non-small cell lung cancer patients: we need smart trials to avoid wasting good bullets.

× No keyword cloud information.

5 in total

1. Consistency of genotyping data from simultaneously collected plasma circulating tumor DNA and tumor-DNA in lung cancer patients.

Authors: Jiali Zhang; Aoran Dong; Shuzhan Li; Xiubao Ren; Xinwei Zhang
Journal: J Thorac Dis Date: 2020-12 Impact factor: 2.895

2. High-level gain of mesenchymal-epithelial transition factor (MET) copy number using next-generation sequencing as a predictive biomarker for MET inhibitor efficacy.

Authors: Shibo Wu; Guodong Li; Xin Zhao; Jianxing Xiang; Analyn Lizaso; Junyi Ye; Chunlei Shi; Lingxiang Chen
Journal: Ann Transl Med Date: 2020-06

3. Ensartinib (X-396) Effectively Modulates Pharmacokinetic Resistance Mediated by ABCB1 and ABCG2 Drug Efflux Transporters and CYP3A4 Biotransformation Enzyme.

Authors: Dimitrios Vagiannis; Eva Novotna; Adam Skarka; Sarah Kammerer; Jan-Heiner Küpper; Si Chen; Lei Guo; Frantisek Staud; Jakub Hofman
Journal: Cancers (Basel) Date: 2020-03-28 Impact factor: 6.639

4. Long non-coding RNA ZNF674-AS1 regulates miR-23a/E-cadherin axis to suppress the migration and invasion of non-small cell lung cancer cells.

Authors: Jie Wang; Sha Liu; Tao Pan; Mingkun Wang; Liang Li; Xiangqian Weng; Panhong Jia; Qi Li; Xiangdong Zhou
Journal: Transl Cancer Res Date: 2021-09 Impact factor: 1.241

5. Clinical characteristics of patients with ROS1 gene rearrangement in non-small cell lung cancer: a meta-analysis.

Authors: Huanhuan Bi; Dunqiang Ren; Xiaoqian Ding; Xiaojiao Yin; Shichao Cui; Caihong Guo; Hongmei Wang
Journal: Transl Cancer Res Date: 2020-07 Impact factor: 1.241

5 in total